# VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

> **NCT06036758** · — · COMPLETED · sponsor: **BioMérieux** · enrollment: 477 (actual)

## Conditions studied

- Acute Kidney Injury
- Stage 2 Acute Kidney Injury
- Stage 3 Acute Kidney Injury

## Interventions

- **DIAGNOSTIC_TEST:** VIDAS® NEPHROCLEAR™ CCL14 Test

## Key facts

- **NCT ID:** NCT06036758
- **Lead sponsor:** BioMérieux
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-17
- **Primary completion:** 2023-12-28
- **Final completion:** 2023-12-28
- **Target enrollment:** 477 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036758, "VIDAS® NEPHROCLEAR Diagnostic Accuracy Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06036758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*